Pembrolizumab-associated Coombs-negative autoimmune hemolytic anemia in metastatic lung adenocarcinoma with concurrent thromboembolism and bacteremia: A case report with literature review
Oncoscience · 11.01.2026 · 132026 · 270
DOI: 10.18632/oncoscience.670 ↗Kurz gefasst
Fallbericht in der Zeitschrift Oncoscience, online erschienen am 11.01.2026. Verfasst von Swapnil Surpur und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Surpur, S., Bhimani, S., Abhinav, T., Sridhar, S., Lazic, T., & Shenoy, A. (2026). Pembrolizumab-associated Coombs-negative autoimmune hemolytic anemia in metastatic lung adenocarcinoma with concurrent thromboembolism and bacteremia: A case report with literature review. Oncoscience, 132026, 270. https://doi.org/10.18632/oncoscience.670
Vancouver
Surpur S, Bhimani S, Abhinav T, Sridhar S, Lazic T, Shenoy A. Pembrolizumab-associated Coombs-negative autoimmune hemolytic anemia in metastatic lung adenocarcinoma with concurrent thromboembolism and bacteremia: A case report with literature review. Oncoscience. 2026;132026:270. doi:10.18632/oncoscience.670
BibTeX
@article{Surpur2026,
author = {Surpur, Swapnil and Bhimani, Sameer and Abhinav, Tushar and Sridhar, Shruthi and Lazic, Teodor and Shenoy, Aadhyaa},
title = {Pembrolizumab-associated Coombs-negative autoimmune hemolytic anemia in metastatic lung adenocarcinoma with concurrent thromboembolism and bacteremia: A case report with literature review},
journal = {Oncoscience},
year = {2026},
volume = {132026},
pages = {270},
doi = {10.18632/oncoscience.670}
}
EUVIMED